Genfit SA (NASDAQ:GNFT)

15.63
Delayed Data
As of 4:00pm ET
 -1.22 / -7.24%
Today’s Change
13.21
Today|||52-Week Range
26.25
-21.46%
Year-to-Date
Is Viking Therapeutics' Stock a Buy?
Feb 18 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close16.85
Today’s open16.35
Day’s range15.33 - 16.64
Volume119,071
Average volume (3 months)56,923
Market cap$697.0M
Data as of 4:00pm ET, 02/25/2020

Growth & Valuation

Earnings growth (last year)-41.89%
Earnings growth (this year)-1.13%
Earnings growth (next 5 years)-21.80%
Revenue growth (last year)-38.84%
P/E ratioNM
Price/Sales--
Price/Book23.36

Competitors

 Today’s
change
Today’s
% change
ASMBAssembly Biosciences...-1.04-5.04%
GTHXG1 Therapeutics Inc+0.25+1.46%
SVASinovac Biotech Ltd0.000.00%
ARDXArdelyx Inc-0.63-8.27%
Data as of 4:00pm ET, 02/25/2020

Financials

Last reporting dateOctober 1, 2019
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$81.4K
Annual profit (last year)-$93.8M
Net profit margin-115,247.83%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Loos, Nord-pas-de-calais

Forecasts